Sanara MedTech Inc.
SMTI
Positions held
Your positionsSMTI isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $322.04M | Enterprise value | $355.14M | Trailing P/E | — | Forward P/E | 64.91 |
| PEG | — | Price / book | 40.57 | Beta | 1.19 | Dividend yield | 0.00% |
| Revenue growth | 9.0% | Earnings growth | — | Gross margin | 93.0% | Operating margin | 6.3% |
| Profit margin | -29.2% | ROE | -1.3% | ROA | 7.6% | Debt / equity | 6.12 |
| Current ratio | 2.58 | Free cash flow | $5.70M | Analyst recommendation | none | Mean target | $35.00 |
| 52w high | $35.34 | 52w low | $16.05 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $28.1M | $27.8M | $27.5M | $26.3M | $25.8M | — |
| Op margin | 6.3% | 9.5% | 10.5% | 11.2% | 9.6% | — |
| Net income | -$0.5M | $0.5M | -$1.6M | -$30.4M | -$2.0M | — |
| Gross margin | 93.0% | 93.1% | 93.2% | 92.9% | 92.5% | — |
| Gross profit | $26.2M | $25.9M | $25.7M | $24.5M | $23.9M | — |
| Operating income | $1.8M | $2.6M | $2.9M | $2.9M | $2.5M | — |
- Revenue +1% vs prior quarter ($28M vs $28M).
- Gross margin 93% (was 93.1% prior quarter).
- Operating margin compressed to 6.3%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $103M | $86.7M | $65.0M | $45.8M | — |
| Op margin | 8.9% | 1.4% | -11.8% | -26.7% | — |
| Net income | -$37.6M | -$9.7M | -$4.3M | -$7.9M | — |
| Gross margin | 92.7% | 90.6% | 87.9% | 86.1% | — |
| Gross profit | $95.6M | $78.5M | $57.1M | $39.5M | — |
| Operating income | $9.1M | $1.2M | -$7.7M | -$12.2M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-08-11 · Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates
2026-08-11 · Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited)
2026-08-08 · MiMedx (MDXG) Q2 2026 Earnings Call Transcript
2026-08-06 · biote Corp. (BTMD) Reports Break-Even Earnings for Q2
2026-07-30 · MiMedx Group Inc (MDXG) (Q2 2026) Earnings Call Highlights: Surgical Growth and Transformative ...
2026-07-29 · MiMedx Group Q2 Earnings Call Highlights
2026-07-29 · MIMEDX Announces Second Quarter 2026 Operating & Financial Results
2026-07-29 · MIMEDX to Acquire Sanara MedTech
Price (daily)
Full chart · RSI · MACD · patterns